TITLE

Paūmėjimo ir imunomoduliuojančio gydymo įtaka išsėtine skleroze sergančių ligonių negaliai

AUTHOR(S)
Giedraitienė, N.; Gencevičiūtė, K.; Kizlaitienė, R.; Kaubrys, G.
PUB. DATE
October 2016
SOURCE
Neurologijos Seminarai;2016, Vol. 20 Issue 4, p212
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction. Most of patients with multiple sclerosis are initially diagnosed with relapsing-remitting form of the disease. It is characterized by clearly defined attacks that are followed by periods of partial or complete recovery (remissions). The presence of a relapse, its clinical presentation, severity, and occurrence rate of relapses are the main indicators of the disease activity as well as the effect iveness of the treatment whereas the rel at ionship between the relapse and its severity, rate of progression, and other indicators of long-term disability is still debatable. Aim of the study. To evaluate the ef-ect of re-apses and immunomodulatory treatment on the neurological disability in multiple sclerosis patients. Materials and methods. We investigated 60 multiple sclerosis patients treated for a multiple sclerosis relapse in Vilnius University Hospital Santariskiu Clinics and 30 multiple sclerosis patients in a remission stage. The disability was assessed using the Extended Disability Status Scale (EDSS). The choice of relapse treatment was based on the international recommendations. Results. The relapse increased the mean EDSS score by 0.49 points assessing EDSS 3 months before the relapse and 3 months after its treatment. 48.3% of patients were treated with methyl- prednisolone, 41.7% with both methylprednisolone and plasmapheresis, and 10% only with plasmapheresis. Pa tients treated with methylprednisolone pulse therapy had EDSS score by 0.92±0.31 points lower than patients treated with methylprednisolone pulse therapy and plasmapheresis (p<0.05). A significant decrease of EDSS score was observed administering 5 g of methylprednisolone while the administration of 3 g and 4 g of methylprednisolone decreased EDSS score by 0.85±0.08 and 0.67±0.21 points respectively (p<0.05). The increase of EDSS score in patients who had used immunomodulatory therapy before the relapse was 1.28±0.61 points compared to 1.91± 1.24 points in patients who had not used immunomodulatory therapy (p<0.05). No significant differences in EDSS scores before, during, and after the relapse were found between the patients who had biologically active interferon beta and the patients who had partly active/ inactive interferon beta (p>0.05). Conclusions. In Vilnius University Hospital Santariskiu Clinics, clinically milder relapse episodes were treated only with methylprednisolone pulse therapy, while more severe cases were treated with methylprednisolone pulse therapy combined with plasmapheresis. More prominent disability regression was observed in patients treated with higher dosages of methyl- prednisolone. Re -apses were milder in patients who had used immunomodulatory therapy before the relapse. Biological activity of interferon beta had no significant effect on the severity of the relapse and the rate of disability regression after the relapse.
ACCESSION #
120535704

 

Related Articles

  • Istin. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p439 

    An encyclopedia entry for Istin is presented. It is a brand name for amlodine, a calcium channel blocker drug designed for the treatment of disorders such as angina pectoris and hypertension.

  • Istin.  // Royal Society of Medicine: Medicines;2002, p313 

    This article presents information on Istin which is a proprietary, prescription-only preparation of the calcium-channel blocker amlodipine besilate. It can be used as an antihypertensive and as an anti-angina drug in the prevention of attacks. This drug is available as tablets.

  • A new home for the holidays. Northrop, Jo // Country Living;Dec93, Vol. 16 Issue 12, p54 

    Describes the Wooley Fox Bed and Breakfast guesthouse in Ligonier, Pennsylvania. Purchase by the author's friends Barbara and Wayne Carroll; Chalet right out of Tirol; Private setting; Elegance and gentility of Ligonier; Spirit of camaraderie.

  • New boxcar commemorates historic Darlington Station.  // Model Railroad News;Apr2008, Vol. 14 Issue 4, p40 

    The article evaluates the O-scale boxcar from Ligonier Valley Rail Road Association in Liognier, Pennsylvania.

  • Good day at Rolling Rock.  // Town & Country;Oct89, Vol. 143 Issue 5113, p180 

    Photo essay with text of the Rolling Rock Hunt Polo Association's annual match held last September in Ligonier, Pa.

  • Walbro to sell Ind. plant.  // Crain's Detroit Business;2/12/96, Vol. 12 Issue 7, p36 

    Reports on Walbro Automotive Corp.'s plans to sell its steel fuel-rail business in Ligonier, Indiana.

  • Burt Kerr Todd. Wehrum, Kasey // Inc.;Dec2006, Vol. 28 Issue 12, p24 

    The article presents an obituary for Burt Kerr Todd, founder of import-export business Kerr-Hays, in Ligonier, Pennsylvania.

  • Genetic Distinctiveness of Alexander Archipelago Wolves (Canis lupus ligoni). Weckworth, Byron V.; Dawson, Natalie G.; Talbot, Sandra L.; Cook, Joseph A. // Journal of Heredity;Jul/Aug2015, Vol. 106 Issue 4, p412 

    A letter to the editor is presented in response to the article "Genetic Distinctiveness of Alexander Archipelago Wolves (Canis lupus ligoni)."

  • Sri Lanka: Amana Takaful transfers life business to new unit.  // MiddleEast Insurance Review;Apr2015, p19 

    The article talks about Amana Takaful, a takaful operator, transferring their insurance business to Amana Takaful Life Limited.

  • Upon this rock. Woodard, Joe // Alberta Report / Newsmagazine;4/24/95, Vol. 22 Issue 19, p36 

    Looks at a conference which dealt with the nature of the church. Sponsored by Ligonier Ministries in Calgary; Definition of Ligonier; Speakers at the seminar; Dr. Edmund Clowney, Donald Carson, John Armstrong; Range of discussions, including `The Foundation of the Church' and `The Love of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics